Business Wire

Six Premier Craft Beverage Equipment Suppliers Merge in $100 Million Deal to Launch First-Ever One-Stop-Shop for All Craft Beverage Needs

20.4.2023 14:30:00 EEST | Business Wire | Press release

Share

Lotus Beverage Alliance, a collective of experienced craft beverage equipment manufacturing companies, today announced that it has officially launched as a company. Six leading American craft beverage equipment suppliers have merged in a $100 million deal to create Lotus Beverage Alliance. The combined capabilities of Lotus Beverage Alliance will enable beverage manufacturers of all sizes to access the most comprehensive array of products spanning every step of production for craft beer, wine, hard cider, spirits, cold brew coffee, ready-to-drink cocktails, kombucha, CBD/THC-infused drinks, and sake beverages.

The six merged companies, Alpha Brewing Operations, GW Kent, Twin Monkeys, Stout Tanks and Kettles, Brewmation, and Automated Extractions, are leaders in craft beverage equipment manufacturing and offer essential infrastructure and technology for diversifying the craft beverage industry. The five founders of the six companies will remain in senior leadership positions at Lotus: Matt Rennerfeldt, John Watt, Kevin Weaver, Josh Van Riper, and Randy Reichwage. John Ansbro, an industry veteran with more than 30 years of experience in equipment manufacturing, has been named Chief Executive Officer for Lotus. Ansbro has held senior executive positions at Alfa Laval, Johnson Controls, and the GEA Group.

“Lotus has everything craft beverage creators need to produce the amazing artisanal products they love, for people who love them,” said John Ansbro, CEO of Lotus Beverage Alliance. “Our team’s proven industry experience includes a deep bench of experts helping to optimize the production of handcrafted beverages for consumers to enjoy.”

Lotus Beverage Alliance brings these leading equipment makers under one roof to become the only end-to-end provider dedicated to crafting possibilities for beverage makers, from nationally-distributed beverage purveyors to the everyday craft enthusiast. Lotus Beverage Alliance produces 1,500+ top-shelf products, including turn-key brewhouse production equipment, 304 stainless steel conical fermenters, brew kettles, IBC totes, multi-capacity tanks, mash tuns, brite tanks, canning systems, automation and control systems, packaging, thermal processes and sanitation equipment, raw ingredient supply, parts, and more.

In another industry first, Lotus introduced a proprietary financing program that offers customers affordable financing options, removing cost barriers for startups and smaller beverage producers. Credit approvals typically take less than 24 hours to provide clients with maximum flexibility.

“What a bold vision to pull together such well-respected leaders of each of their respective craft beverage supplier channel segments. The result of this merger for craft beverage makers is sure to be exponential growth and continued beverage innovation,” said Banjo Bandolas, Director of Advertising and Sales at ProBrewer.com. “Lotus appears to be a first-mover by creating a one-stop-shop for craft brewers and companies moving into ‘beyond beer’ products. I look forward to seeing where it evolves.”

Beverage makers who select Lotus Beverage Alliance as their trusted equipment partner can expect:

  • Responsive and expert customer service
  • A one-stop-shop supply chain for all production needs
  • Ready-to-ship production parts and equipment
  • High-performance equipment with extended life cycles
  • Seamless equipment integration with several third-party brands
  • Opportunities for reduced operating costs and downtime through automation
  • Greater uptimes and efficiencies in production processes
  • Post-purchase technical and operations support
  • Proprietary purchase financing program with typical approval in 24 hours

Lotus Beverage Alliance offers extensive support for startups and scale-ups, including:

  • Brewing and Distilling
  • Quick Ship Equipment and Parts
  • Packaging
  • Automation and Controls
  • Extraction Processing
  • Beverage Production Support

Following the six-way merger, the Lotus Beverage Alliance ownership structure includes the founders from all six businesses. Additionally, Lotus has implemented an employee ownership program, at no cost to the employees. Employee ownership has been extended to every single employee throughout the organization. Research has shown that broad-based employee ownership programs improve worker retention, reduce income disparity, and result in higher margins, as well as improved growth and operating efficiencies across various aspects of a business. Lotus collaborated with Ownership Works (https://ownershipworks.org/) in this employee ownership program’s creation. The Lotus merger was facilitated by Ronin Equity Partners, a New York-based investment firm with a long-term growth focus. Ronin is also an investor in Lotus.

Lotus Beverage Alliance will be an exhibitor at the Specialty Coffee Expo in Portland, Oregon, Apr. 21–23, at Booth #456; and at the Craft Brewers Conference in Nashville, Tennessee, May 7-10, 2023 at Booths #500 and #945.

About L otus Beverage Alliance:

Lotus Beverage Alliance is a collective group of experienced companies with extensive knowledge and professional insight into the craft beverage industry. The organization was formed to bring excitement and resources to craft brewing companies by providing an advanced and comprehensive product line, knowledgeable technical guidance, immediate equipment and parts availability, and an excellent customer service team. To learn more about Lotus Beverage Alliance, please visit lotusbevalliance.com. Crafting possibilities.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For Media Inquiries, Please Contact:

Craft beer media:
Jesse P. Cutler, JP Cutler Media, 415.318.9663, jesse@jpcutlermedia.com

Wine/spirits/specialty beverage media:
Michelle Barry, Chameleon Collective
603.809.2748
LotusBeverage@chameleon.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye